Aprea Therapeutics, Inc. (APRE)
0.745
+0.02
(+2.34%)
USD |
NASDAQ |
Jul 10, 16:00
0.7301
-0.01
(-2.00%)
After-Hours: 20:00
Aprea Therapeutics EPS Diluted (Quarterly) : -0.2239 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.2239 |
| December 31, 2025 | -0.3194 |
| September 30, 2025 | -0.4664 |
| June 30, 2025 | -0.5324 |
| March 31, 2025 | -0.6561 |
| December 31, 2024 | -0.4861 |
| September 30, 2024 | -0.637 |
| June 30, 2024 | -0.5844 |
| March 31, 2024 | -0.6693 |
| December 31, 2023 | -0.9215 |
| September 30, 2023 | -0.8579 |
| June 30, 2023 | -0.8734 |
| March 31, 2023 | -1.343 |
| December 31, 2022 | -18.39 |
| September 30, 2022 | -2.323 |
| June 30, 2022 | -86.72 |
| March 31, 2022 | -7.248 |
| December 31, 2021 | -7.176 |
| September 30, 2021 | -8.904 |
| Date | Value |
|---|---|
| June 30, 2021 | -9.677 |
| March 31, 2021 | -9.127 |
| December 31, 2020 | -14.53 |
| September 30, 2020 | -11.63 |
| June 30, 2020 | -15.51 |
| March 31, 2020 | -8.930 |
| December 31, 2019 | -12.44 |
| September 30, 2019 | -6.030 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| United Therapeutics Corp. | 5.824 |
| Onconetix, Inc. | -67.06 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.288M |
| Total Expenses (Quarterly) | 3.288M |
| Enterprise Value | -36.81M |
| Earnings Yield | -207.0% |
| Normalized Earnings Yield | -206.99 |